Cutler Group’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-869
Closed -$22.7K 2672
2023
Q4
$21K Buy
869
+669
+335% +$15.2K ﹤0.01% 1943
2023
Q3
$4K Buy
+200
New +$4.83K ﹤0.01% 2948
2023
Q1
Sell
-100
Closed -$2K 4074
2022
Q4
$2K Sell
100
-1,100
-92% -$27.1K ﹤0.01% 3677
2022
Q3
$29K Buy
+1,200
New +$33.2K ﹤0.01% 2323
2022
Q2
Sell
-400
Closed -$12.9K 5174
2022
Q1
$15K Sell
400
-1,000
-71% -$38.8K ﹤0.01% 3279
2021
Q4
$64K Buy
1,400
+1,000
+250% +$47.7K ﹤0.01% 2202
2021
Q3
$18K Buy
400
+300
+300% +$14K ﹤0.01% 3432
2021
Q2
$4K Buy
+100
New +$4.53K ﹤0.01% 4573
2021
Q1
Sell
-6,200
Closed -$254K 5835
2020
Q4
$254K Buy
+6,200
New +$242K 0.01% 952
2020
Q2
Sell
-800
Closed -$24.9K 4524
2020
Q1
$22K Hold
800
﹤0.01% 2235
2019
Q4
$27K Hold
800
﹤0.01% 2027
2019
Q3
$25K Buy
+800
New +$27.3K ﹤0.01% 2019
2019
Q1
Sell
-900
Closed -$28.3K 4255
2018
Q4
$24K Buy
900
+300
+50% +$9.3K ﹤0.01% 1984
2018
Q3
$23K Buy
600
+300
+100% +$11K ﹤0.01% 2147
2018
Q2
$10K Buy
+300
New +$10.5K ﹤0.01% 2670

Other funds holding FFTY

Cutler Group's FFTY Position: Q1 2024 in Review

Cutler Group sold out of CapForce IBD 50 ETF (FFTY) in Q1 2024, closing a stake of 869 shares — an estimated $22.7K sold.

Cutler Group first reported a position in FFTY in Q2 2018 and held it in 15 quarters. The position peaked at $254K in Q4 2020. 40 funds tracked by Wall St. Rank hold FFTY as of Q1 2024.

  • Cutler Group reported no remaining CapForce IBD 50 ETF position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 869 CapForce IBD 50 ETF shares in Q1 2024, an estimated $22.7K.
  • Cutler Group first reported a position in CapForce IBD 50 ETF in Q2 2018 and held it in 15 quarters.
  • Cutler Group's CapForce IBD 50 ETF position peaked at $254K in Q4 2020.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.